Bøttcher, S. G.
Novo Nordisk (Denmark)
3 papers on CoChat
Most cited papers
- Verified
Ultra‐long‐acting insulin degludec has a flat and stable glucose‐lowering effect in type 2 diabetes
Heise, T., Nosek, L., Bøttcher, S. G., Hastrup, H., & Haahr, H. (2012) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 331
- Verified
Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)
Buse, J. B., Vilsbøll, T., Thurman, J., Blevins, T. C., Langbakke, I. H., Bøttcher, S. G., & Rodbard, H. W. (2014) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 259
- Verified
Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment
Kiss, I., Arold, G., Roepstorff, C., Bøttcher, S. G., Klim, S., & Haahr, H. (2014) · Clinical Pharmacokinetics
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 75
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free